Management of Acinetobacter Infections in the Immunosuppressed Host

Resource type
Book Section
Authors/contributors
Title
Management of Acinetobacter Infections in the Immunosuppressed Host
Abstract
Acinetobacter infections have emerged as an important pathogen in transplant recipients. It is a major cause of multidrug-resistant nosocomial infections, particularly pneumonia and bloodstream infections, and is associated with high morbidity and mortality. Given the organism’s propensity to develop resistance to multiple classes of antibiotics, treatment options can be limited but frequently include carbapenems, polymyxins, sulbactams, tetracyclines, and glycylcyclines. Infection prevention measures are critical for preventing transmission among patients and avoiding hospital outbreaks.
Book Title
Emerging Transplant Infections
Date
2021
Publisher
Springer International Publishing
Place
Cham
Pages
371-390
ISBN
978-3-030-01751-4
Accessed
10/23/21, 9:33 AM
Language
en
Library Catalog
DOI.org (Crossref)
Citation
Baneman, E., & Rana, M. M. (2021). Management of Acinetobacter Infections in the Immunosuppressed Host. In M. I. Morris, C. N. Kotton, & C. Wolfe (Eds.), Emerging Transplant Infections (pp. 371–390). Springer International Publishing. https://doi.org/10.1007/978-3-030-01751-4_21-1